London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding. The amount was not disclosed. Sanner Ventures and Breed Reply (a previous investor) led the round.
Amiko Digital Health’s flagship product, Respiro, consists of two parts. The first part is a connected inhaler for respiratory disease patients, which measures compliance, lung...
